Diabetes News

Employing evidence-based guidelines, multidisciplinary teams, and institution-specific clinical pathways provides the best approach to guide clinicians through this multifaceted problem (Diabetes, Obesity and Metabolism)

The in vitro effects of CRT on these functions are consistent with CRT’s potent effects on wound healing in the diabetic mouse. These studies implicate CRT as a potential powerful topical therapeutic agent for the treatment of diabetic and other chronic wounds (Wound Repair and Regeneration)

These findings summarise all available trial evidence regarding the use of dressings to heal diabetic foot ulcers. More expensive dressings may offer no advantages in terms of healing than cheaper basic dressings (Diabetologia)

MacroCure currently manufactures and markets its lead product, CureXcell™, in Israel for hard-to-heal wound treatment. The cell therapy company has its regulatory strategy in place for market approval in North America and Europe. CureXcell™, a cell based therapy for hard to heal wounds, to restore the wound healing process (You Tube video from MacroCure)